C-Reactive Protein and Erythrocyte Sedimentation Rate Testing: Should Both Be Ordered? [Utilization Spotlight]

shutterstock_138753278Since 2012, we have been publishing a Utilization Spotlight in every issue of the Communiqué. Each Spotlight offers a quick view of utilization management best practices in action. This Spotlight is from November 2012

Overview

Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are nonspecific tests for acute inflammatory processes. Studies have demonstrated equivalent performance of ESR and CRP in a majority of patient populations, with the exception of patients with temporal arteritis and polymyalgia rheumatica. Mayo Clinic identified and evaluated patient populations where ESR and CRP were ordered concurrently to determine whether there was any added value to ordering both tests.


Situation

Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are nonspecific tests for acute inflammatory processes. Although they largely generate the same information, both tests are often requested. Studies have demonstrated equivalent performance of ESR and CRP in a majority of patient populations, with the exception of patients with temporal arteritis and polymyalgia rheumatica. At Mayo Clinic, we identified and evaluated patient populations where ESR and CRP were ordered concurrently to determine whether there was any added value to ordering both tests.

Method

Retrospective ESR and CRP results from tests that were ordered alone (ESR n=26,346, CRP n=11,333) and simultaneously (n=29,702) on the same patient on the same day were evaluated over a one year period (11/1/08 to 10/31/09). The concordance between positive and negative ESR and CRP results was evaluated based on ESR cutoffs for positive results of >22 millimeters/hour for males or >29 millimeters/ hour for females and CRP concentrations >8 mg/L. The diagnosis ICD-9 codes associated with each laboratory test order were obtained from the electronic medical record for the simultaneous ESR and CRP results and were analyzed for agreement. The diagnosis codes were then categorized by indication for testing and the groups were sorted to associate each set of patient results with a single indication for testing when multiple indications were found.

11fig3

Results

In 95 percent of cases, ESR and CRP were ordered for the same medical indication. ESR was measured alone for 48 percent of total requests, while CRP was measured alone for 27 percent. The overall concordance between ESR and CRP results was 81 percent (16 percent positive, 65 percent negative). The indications for testing with the greatest concordance included inflammation (86 percent, n=3315) and neoplasm (83 percent, n=571). The categories with the least concordance included polymyalgia rheumatica (73 percent, n=368) and systemic lupus erythematosus (74 percent, n=410). Prosthetic joint/device infection (n=5572) and a variety of rheumatic diseases including rheumatoid arthritis (n=2215) had approximately 80 percent concordance.

Summary

We concluded that ESR and CRP are being ordered for the same purpose. ESR was ordered alone twice as frequently as CRP alone. When CRP was ordered, ESR was ordered concurrently 73 percent of the time despite an overall analytical concordance of 81 percent. These data demonstrate that antiquated tests such as ESR continue to be routinely utilized despite emergence of newer, more automated assays such as CRP. Furthermore, these findings suggest that there is redundancy in test orders for assessing acute inflammation for most clinical indications and identifies opportunities for the clinical laboratory to provide education to health care providers and subsequently guide proper test utilization.

kschrib

Kelley Schreiber

Kelley Schreiber is a Marketing Channel Manager at Mayo Medical Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her new kitten, and exploring new foods.